Skip to main content
Sign In

Welcome to the Barbara Davis Center for Diabetes at the University of Colorado School of Medicine on the Anschutz Medical Campus in Aurora, Colorado.

Barbara Davis Center Banner Image
 

ATDC 2014 Keystone Conference

Thursday, July 17, 2014 - Sunday, July 20, 2014



Wednesday, July 16, 2014

​5:00 – 7:00 PM     Early Registration

 

Thursday, July 17, 2014

12:00 – 12:15 PM    Welcome and Introductory Remarks: Satish Garg, MD

PLENARY ONE: Improving Diabetes Outcomes Chair - Matthew Riddle, MD

 12:15 –12:40 PM    

How Diabetes Outcomes Have Changed Over the Past 30 Years - Philip Home, MD AUDIO

 12:40 – 1:05 PM     

Why Obese People are Unable to Keep Weight Off after Losing itRobert Ratner, MD AUDIO

   1:05 – 1:30 PM      

What Should Be the Therapeutic Glycemic Target in Intensive Care Units?Irl Hirsch, MD AUDIO

   1:30 – 1:55 PM      

Contemporary Pediatric Diabetes Care - Tadej Battelino, MD AUDIO

PLENARY TWO: Controversies in Diabetes Chair - Robert Ratner, MD

   2:50 – 3:15 PM      

Should We Count Protein and Fat for Bolus Insulin Dose? Howard Wolpert, MD AUDIO

   3:15 – 3:40 PM     

Do Postprandial Glycemic Excursions Impact Cardiovascular Risk? V. Mohan, MD  AUDIO

   3:40 – 4:05 PM      

Role of Pramlintide in Diabetes CareMatthew Riddle, MD AUDIO

   4:05 – 4:30 PM      

Which Guidelines to Use for Gestational Diabetes – ACOG or ADA? - Linda Barbour, MD AUDIO


Friday, July 18, 2014

   7:55 – 8:05 AM      

Welcome and Introductory Remarks - Satish Garg, MD       

PLENARY THREE: Type 1 Diabetes – Immunology and Cell Therapy Chair - Philip Home, MD

  8:05 – 8:30 AM      

Knowledge gains in type 1 diabetes pathogenesis – New opportunities for the next generation of disease biomarkers Mark Atkinson, PhD AUDIO

  8:30 – 8:55 AM      

Is Primary Prevention a Realistic Expectation? Marian Rewers, PHD  AUDIO

  8:55 – 9:20 AM      

Immunomodulatory Trials; What Will Work? - Peter Gottlieb, MD AUDIO

  9:20 – 9:45 AM      

Tri-Molecular Complex for Immune Intervention?  - Aaron Michels, MD AUDIO 

  9:45 –10:10 AM      

Beta-Cell Regeneration or Replacement – Hype or Hope? - Jay Skyler, MD  AUDIO                               

PLENARY FOUR: Closed Loop Therapy – State of the Art  Chair - Georgeanna Klingensmith, MD

10:50 –11:15 AM     

Early Closed Loop Experience in Children - Tadej Battelino, MD AUDIO

 11:15 –11:40 AM    

Wearable Artificial PancreasBoris Kovatchev, PhD AUDIO

 11:40 –12:05 PM    

Making Diabetes Managem​ent Disappear: A Bionic Pancreas for One and All - Ed Damiano, PhD AUDIO

 12:05 –12:30 PM    

The Role of Glucagon in Closed Loop Treatment for T1D - Kenneth Ward, MD AUDIO

PLENARY FIVE: Diabetes Management Issues Chair - Sarit Polsky, MD

  2:00 – 2:25 PM       

Hypoglycemic Unawareness Philip Home, MD  AUDIO

  2:25 – 2:50 PM       

Explanation for the ACCORD Outcomes?Matthew Riddle, MD  AUDIO

  2:50 – 3:15 PM       

How to Successfully Manage T1DM in the Cheapest Way Possible Irl Hirsch, MD AUDIO

4:00 – 5:00 PM MEET THE PEERS SESSION (A&B Pediatrics, C&D Adult)

Session A. & B. Meet the Peers – Pediatric

A. Providers: Chairs - T. Battelino & R. Slover   

B. Educators: Chair -  R. Hink

Session C. & D. Meet the Peers – Adult

C. Providers: Chairs - P. Home & S. Garg

D. Educators: Chairs - C. Beatson & T. Thompson


Saturday, July 19, 2014

   7:50 – 7:55 AM      

Welcome and Introductory Remarks - Satish Garg, MD

   7:55 – 8:25 AM      

FDA’s Perspective on Closed-Loop Studies

Keynote Speaker: Courtney H. Lias, PhD; Director, Division of Chemistry and Toxicology Devices at FDA

PLENARY SIX: Special Issues in Diabetes Chair - Irl Hirsch, MD

   8:35 – 9:00 AM      

Role of Biosimilars in Diabetes Care Philip Home, MD AUDIO

   9:00 – 9:25 AM      

Role of CGM for Achieving Glycemic Targets - Howard Wolpert, MD AUDIO

   9:25 – 9:50 AM      

Fibrocalculous Pancreatic Diabetes - V. Mohan, MD AUDIO

 9:50 – 10:10 AM      

Management of T1D Using Telemedicine Paul Wadwa, MD   AUDIO                            

PLENARY SEVEN: Obesity and Type 2 Diabetes Chair - Linda Barbour, MD

10:45 –11:10 AM     

Role of Lifestyle ModificationsJames Hill, PhD  AUDIO

11:10 –11:35 AM     

Pharmacological Approaches to Weight Loss Daniel Bessesen, MD  AUDIO                              

11:35 –12:00 PM     

Role of Bariatric Surgery in Obesity & DiabetesPhillip Schauer, MD AUDIO

12:00 –12:30 PM     

Novel Approaches to Weight LossRobert Eckel, MD AUDIO

2:00 – 4:00 PM CONCURRENT SESSIONS 1 & 2

SESSION 1: Pediatric Diabetes Challenges Chair - Robert Slover, MD

2:00 – 2:20 PM   

Toddlers Peter Chase, MD

2:20 – 2:40 PM   

Teenagers G. Klingensmith, MD

2:40 – 3:00 PM   

T2D in Youth Tadej Battelino, MD

SESSION 2: Challenges with Diabetes Complications Chair - Satish Garg, MD

2:00 – 2:20 PM   

MicrovascularJay Skyler, MD

2:20 – 2:40 PM   

MacrovascularWill Hiatt, MD

2:40 – 3:00 PM   

Neuropathy​Daniel Bessesen, MD     

Patient/Provider Panel: Question & Answer Session

4:00 – 5:15 PM    

Pediatric Panel: R. Slover, G. Klingensmith, P. Chase, T. Battelino, M. Rewers 

Patients:

-Mollendor Family

-Zarecki Family

-Mario Medina

Adult Panel: S. Garg, A. Michels, J. Skyler, P. Gottlieb, H. Wolpert, I. Hirsch

Patients:

-Adam Smith

-Ted Miller

-Duncan Harvey & Robin Juarez

-Clark Eckel

-Lynda Bergeron

 

Sunday, July 20, 2014

  7:20 – 7:30 AM       

Opening Remarks Satish Garg, MD and Jay Skyler, MD

  7:30 – 8:00 AM       

Delivery of Quality Care in the Evolving Payor Landscape:

Keynote Speaker: Robert Ratner, MD  AUDIO

PLENARY EIGHT: Cardiovascular Disease and Diabetes Chair - Marian Rewers, PHD

   8:00 – 8:25 AM      

Is CVD Outcome for Diabetes Drugs Appropriate? - Will Hiatt, MD AUDIO

   8:25 – 8:50 AM      

Recent and Ongoing Cardiovascular Outcomes Trials with Diabetes Drugs - Jay Skyler, MD AUDIO

    8:50 – 9:15 AM      

Rationale for ADA Treatment Guidelines for CVD Prevention Robert Ratner, MD AUDIO

   9:15 – 9:40 AM      

Lipid Targets & Treatments 2014​ Robert Eckel, MD AUDIO​

10:10 –10:15 AM     

Concluding Remarks & Departures Satish Garg, MD